RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …
S Taka, P Tzani-Tzanopoulou… - Allergy, asthma & …, 2019 - synapse.koreamed.org
MicroRNAs (miRs) are single-stranded RNAs of 18-25 nucleotides. These molecules regulate gene expression at the post-transcriptional level; several of these are differentially …
Respiratory syncytial virus (RSV) is a major cause of serious lower respiratory tract infections in children< 5 years of age worldwide and repeated infections throughout life …
E Ostrycharz, B Hukowska-Szematowicz - International Journal of …, 2022 - mdpi.com
Over time, more and more is becoming known about micro-players of great significance. This is particularly the case for microRNAs (miRNAs; miR), which have been found to …
HC Bergeron, RA Tripp - Expert Opinion on Investigational Drugs, 2022 - Taylor & Francis
Introduction Respiratory syncytial virus (RSV) is a leading cause of serious lower respiratory tract infection (LRTI) in infants and young children. Palivizumab is an RSV-specific …
Recent high-throughput sequencing revealed that only 2% of the transcribed human genome codes for proteins, while the majority of transcriptional products are non-coding …
Prostaglandin D2 (PGD2) signals through PGD2 receptor 2 (DP2, also known as CRTH2) on type 2 effector cells to promote asthma pathogenesis; however, little is known about its role …
BS Graham - Current opinion in immunology, 2019 - Elsevier
Highlights•Immunological goals for vaccination depend on whether it is for primary induction or boosting of pre-existing immunity.•Boosting neutralizing activity is the major goal for …
HC Bergeron, LM Kauvar… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Background: Respiratory syncytial virus (RSV) is a poor inducer of antiviral interferon (IFN) responses which result in incomplete immunity and RSV disease. Several RSV proteins …